Anika extends viscoelastic deal with Bausch & Lomb
This article was originally published in Clinica
Executive Summary
Anika Therapeutics has renewed a multi-year agreement with Bausch & Lomb (B&L) to supply the eyecare multinational with its line of Amvisc and Amvisc Plus viscoelastics. The products, composed of hyaluronic acid, are used in cataract surgery to maintain the eye's structural integrity during lens exchange.